abs202.txt	glioblastoma	(gbm)		the	most	common	and	aggressive	primary	brain	cancer	carriesa	life	expectancy	of	12-15	months	short	is	due	in	part	tothe	inability	current	treatment	consisting	surgical	resection	followedby	radiation	chemotherapy	to	eliminate	invasive	tumor	foci	ofthese	may	be	improved	with	tumoricidal	human	mesenchymal	stem	cells	(mscs)	mscs	exhibit	potent	tropism	can	engineered	express	therapeuticproteins	that	kill	advancements	preclinical	models	indicate	thatsurgical	induces	premature	msc	loss	reduces	therapeutic	efficacy	by	seeding	on	a	biodegradablepoly(lactic	acid)	(pla)	scaffold	delivery	into	cavityon	pla	restores	cell	retention	persistence	killing	tostudy	effects	msc-seeded	implantation	gbm	an	accurate	preclinicalmodel	needed	here	we	provide	protocol	for	image-guidedtumor	immune-deficient	mice	followed	scaffoldimplantation	are	lentiviral	constructs	constitutivelyexpress	secrete	tnfÎ±-related	apoptosis-inducing	ligand	(trail)	aswell	as	green	fluorescent	protein	(gfp)	allow	tracking	similarly	u87	mcherry	firefly	luciferase	providing	dual	fluorescent/luminescent	while	currently	used	forinvestigating	mediated	therapeutics	this	could	bemodified	investigate	impact	other	gbminterventions
